The Role of Interim PET/CT on Survival in Diffuse Large B Cell Lymphoma
- 8 July 2021
- journal article
- research article
- Published by Elsevier BV in Clinical Lymphoma Myeloma and Leukemia
- Vol. 21 (11), e922-e927
- https://doi.org/10.1016/j.clml.2021.06.016
Abstract
No abstract availableThis publication has 43 references indexed in Scilit:
- Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano ClassificationJournal of Clinical Oncology, 2014
- Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working GroupJournal of Clinical Oncology, 2014
- Intensification treatment based on early FDG‐PET in patients with high‐risk diffuse large B‐cell lymphoma: a phase II GELTAMO trialBritish Journal of Haematology, 2014
- An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmaxEuropean Journal of Nuclear Medicine and Molecular Imaging, 2013
- CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program StudyBlood, 2013
- Interim FDG PET/CT as a prognostic factor in diffuse large B-cell lymphomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2013
- Interim PET/CT-based prognostic model for the treatment of diffuse large B cell lymphoma in the post-rituximab eraAnnals of Hematology, 2012
- SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphomaBlood, 2011
- Risk-Adapted Dose-Dense Immunochemotherapy Determined by Interim FDG-PET in Advanced-Stage Diffuse Large B-Cell LymphomaJournal of Clinical Oncology, 2010
- Revised Response Criteria for Malignant LymphomaJournal of Clinical Oncology, 2007